Genomic Valley Biotech fundamental analysis

GVBL

26

0.00 (0.00%)
Last updated on 24 Feb, 2026 | 15:15 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Genomic Valley Biotech Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

31.09

Sector P/B

1.45

Sec. Div. Yield

0.44

Genomic Valley Biotech Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 31.09. Its P/B Ratio stands at 0, while the sector’s is 1.45. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.44%.

Genomic Valley Biotech Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Genomic Valley Biotech reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost